Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain
Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling
The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor
Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland
Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK
